HCPCS drug code · CMS crosswalk
Enoxaparin Sodium J-Code / HCPCS Code
In short
Enoxaparin Sodium is billed under HCPCS J1650 — Injection, enoxaparin sodium, 10 mg. One billing unit is 10 mg. CMS's crosswalk lists 128 Enoxaparin Sodium NDCs under this code.
Reference
- J1650
- Injection, enoxaparin sodium, 10 mgBilling unit: 10 mg
- Labelers
- Amphastar Pharmaceuticals, Inc.; Apotex Corp; BE Pharmaceuticals Inc.; BluePoint Laboratories; Civica, Inc.; FreseniUS Kabi USA, LLC; Hepalink USA, Inc.; Meitheal Pharmaceuticals Inc.and 5 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Enoxaparin Sodium units and claim line
Enter the dose given to get the J1650 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Enoxaparin Sodium NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00548-5601-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 10 × 0.3 | 30 |
| 00548-5602-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 10 × 0.4 | 40 |
| 00548-5603-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 10 × 0.6 | 60 |
| 00548-5604-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 10 × 0.8 | 80 |
| 00548-5605-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 10 × 1 | 100 |
| 00548-5606-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 10 × 0.8 | 120 |
| 00548-5607-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 10 × 1 | 150 |
| 00548-5608-00 | J1650 | Amphastar Pharmaceuticals, Inc. | 3 | 30 |
| 00781-3238-63 | J1650 | Sandoz Inc. | 10 × 0.3 | 30 |
| 00781-3246-64 | J1650 | Sandoz Inc. | 10 × 0.4 | 40 |
| 00781-3256-66 | J1650 | Sandoz Inc. | 10 × 0.6 | 60 |
| 00781-3262-68 | J1650 | Sandoz Inc. | 10 × 0.8 | 80 |
| 00781-3268-69 | J1650 | Sandoz Inc. | 10 × 1 | 100 |
| 00781-3298-68 | J1650 | Sandoz Inc. | 10 × 0.8 | 120 |
| 00781-3299-69 | J1650 | Sandoz Inc. | 10 × 1 | 150 |
| 00955-1003-10 | J1650 | Sanofi-Aventis U.S. LLC | 10 × 0.3 | 30 |
| 00955-1004-10 | J1650 | Sanofi-Aventis U.S. LLC | 10 × 0.4 | 40 |
| 00955-1006-10 | J1650 | Sanofi-Aventis U.S. LLC | 10 × 0.6 | 60 |
| 00955-1008-10 | J1650 | Sanofi-Aventis U.S. LLC | 10 × 0.8 | 80 |
| 00955-1010-10 | J1650 | Sanofi-Aventis U.S. LLC | 10 × 1 | 100 |
| 00955-1012-10 | J1650 | Sanofi-Aventis U.S. LLC | 10 × 0.8 | 120 |
| 00955-1015-10 | J1650 | Sanofi-Aventis U.S. LLC | 10 × 1 | 150 |
| 00955-1016-01 | J1650 | Sanofi-Aventis U.S. LLC | 3 | 30 |
| 16714-0006-10 | J1650 | Northstar RxLLC | 10 × 0.3 | 30 |
| 16714-0016-10 | J1650 | Northstar RxLLC | 10 × 0.4 | 40 |
| 16714-0026-10 | J1650 | Northstar RxLLC | 10 × 0.6 | 60 |
| 16714-0036-10 | J1650 | Northstar RxLLC | 10 × 0.8 | 80 |
| 16714-0046-10 | J1650 | Northstar RxLLC | 10 × 1 | 100 |
| 16714-0056-10 | J1650 | Northstar RxLLC | 10 × 0.8 | 120 |
| 16714-0066-10 | J1650 | Northstar RxLLC | 10 × 1 | 150 |
| 25021-0410-70 | J1650 | Sagent Pharmaceuticals | 10 × 0.3 | 30 |
| 25021-0410-71 | J1650 | Sagent Pharmaceuticals | 10 × 1 | 100 |
| 25021-0410-76 | J1650 | Sagent Pharmaceuticals | 10 × 0.4 | 40 |
| 25021-0410-77 | J1650 | Sagent Pharmaceuticals | 10 × 0.6 | 60 |
| 25021-0410-78 | J1650 | Sagent Pharmaceuticals | 10 × 0.8 | 80 |
| 25021-0411-70 | J1650 | Sagent Pharmaceuticals | 10 × 0.8 | 120 |
| 25021-0411-71 | J1650 | Sagent Pharmaceuticals | 10 × 1 | 150 |
| 60505-0792-04 | J1650 | Apotex Corp | 10 × 0.4 | 40 |
| 60505-0794-04 | J1650 | Apotex Corp | 10 × 0.8 | 80 |
| 60505-0795-04 | J1650 | Apotex Corp | 10 × 1 | 100 |
| 60505-0796-04 | J1650 | Apotex Corp | 10 × 0.8 | 120 |
| 60505-0798-04 | J1650 | Apotex Corp | 10 × 1 | 150 |
| 63323-0531-90 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.8 | 80 |
| 63323-0531-98 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.8 | 80 |
| 63323-0533-83 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.3 | 30 |
| 63323-0533-93 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.3 | 30 |
| 63323-0535-87 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.4 | 40 |
| 63323-0535-98 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.4 | 40 |
| 63323-0539-03 | J1650 | FreseniUS Kabi USA, LLC | 3 | 30 |
| 63323-0559-65 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.3 | 30 |
| 63323-0559-93 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.3 | 30 |
| 63323-0564-65 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.4 | 40 |
| 63323-0564-97 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.4 | 40 |
| 63323-0566-65 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.6 | 60 |
| 63323-0566-98 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.6 | 60 |
| 63323-0584-65 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.8 | 80 |
| 63323-0584-99 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.8 | 80 |
| 63323-0586-65 | J1650 | FreseniUS Kabi USA, LLC | 10 × 1 | 100 |
| 63323-0586-96 | J1650 | FreseniUS Kabi USA, LLC | 10 × 1 | 100 |
| 63323-0589-94 | J1650 | FreseniUS Kabi USA, LLC | 10 × 1 | 150 |
| 63323-0605-84 | J1650 | FreseniUS Kabi USA, LLC | 10 × 1 | 100 |
| 63323-0605-94 | J1650 | FreseniUS Kabi USA, LLC | 10 × 1 | 100 |
| 63323-0607-88 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.6 | 60 |
| 63323-0607-98 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.6 | 60 |
| 63323-0655-99 | J1650 | FreseniUS Kabi USA, LLC | 10 × 0.8 | 120 |
| 68001-0457-42 | J1650 | BluePoint Laboratories | 10 × 0.3 | 30 |
| 68001-0458-42 | J1650 | BluePoint Laboratories | 10 × 0.4 | 40 |
| 68001-0459-42 | J1650 | BluePoint Laboratories | 10 × 0.6 | 60 |
| 68001-0460-42 | J1650 | BluePoint Laboratories | 10 × 0.8 | 80 |
| 68001-0461-42 | J1650 | BluePoint Laboratories | 10 × 1 | 100 |
| 68001-0462-42 | J1650 | BluePoint Laboratories | 10 × 0.8 | 120 |
| 68001-0463-42 | J1650 | BluePoint Laboratories | 10 × 1 | 150 |
| 68001-0464-41 | J1650 | BluePoint Laboratories | 3 | 30 |
| 68001-0633-42 | J1650 | BluePoint Laboratories | 10 × 0.3 | 30 |
| 68001-0634-42 | J1650 | BluePoint Laboratories | 10 × 0.4 | 40 |
| 68001-0635-42 | J1650 | BluePoint Laboratories | 10 × 0.6 | 60 |
| 68001-0636-42 | J1650 | BluePoint Laboratories | 10 × 0.8 | 80 |
| 68001-0637-42 | J1650 | BluePoint Laboratories | 10 × 1 | 100 |
| 68001-0638-42 | J1650 | BluePoint Laboratories | 10 × 0.8 | 120 |
| 68001-0639-42 | J1650 | BluePoint Laboratories | 10 × 1 | 150 |
Enoxaparin Sodium: common questions
- What is the J-code for Enoxaparin Sodium?
- Enoxaparin Sodium is billed under HCPCS J1650 — Injection, enoxaparin sodium, 10 mg. One billing unit is 10 mg. CMS's crosswalk lists 128 Enoxaparin Sodium NDCs under this code.
- How many J1650 billing units are in a package of Enoxaparin Sodium?
- CMS lists 30 to 150 billing units per package, depending on the NDC, where one unit is 10 mg. Units to report are based on the dose given, not the package.
- Is J1650 a CPT code?
- No. J1650 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.